Want to see WAT full AI Analyst Report?
WAT Stock Chart & Stats
$327.77
-$3.31(-0.88%)
At close: 4:00 PM EST
$327.77
-$3.31(-0.88%)
Day’s Range― - ―
52-Week Range$275.05 - $414.15
Previous CloseN/A
Volume75.18K
Average Volume (3M)831.77K
Market Cap
$36.23B
Enterprise Value$30.10K
Total Cash (Recent Filing)$462.00M
Total Debt (Recent Filing)$5.57B
Price to Earnings (P/E)45.4
Beta0.74
Next Earnings
Aug 04, 2026EPS Estimate
3.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.88
Shares Outstanding98,185,850
10 Day Avg. Volume653,316
30 Day Avg. Volume831,775
Financial Highlights & Ratios
PEG Ratio75.61
Price to Book (P/B)8.83
Price to Sales (P/S)7.14
P/FCF Ratio41.87
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$403.33Price Target Upside23.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)14.52
Revenue Forecast (FY)$6.44B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & ServicesWaters' installed base drives recurring consumables, service contracts and software revenue, creating higher‑margin annuity streams. That business model supports predictable mid‑term revenue, retention and pricing leverage across pharma and regulated labs, strengthening durable cash generation.
Reaccelerating Revenue GrowthTTM revenue reaccelerating ~19.1% indicates recovering demand across legacy and acquired businesses. Sustained top‑line momentum provides scale to absorb integration costs, enhances multi‑quarter visibility for capital allocation, and creates a base for margin recovery and reinvestment.
Synergy Delivery And Guided ExecutionConcrete synergy targets, a 180‑day integration plan and raised guidance show active execution. Delivering cost and revenue synergies reduces structural costs, accelerates margin restoration, and validates management's integration capability—supporting durable EPS improvement once synergies scale.
Bears Say
Sharp Margin CompressionA fall in net margin from ~20.3% to ~11.9% is a material reset driven by acquisition accounting, higher costs and adverse mix. Persistent margin weakness undermines ROE and earnings quality, forcing longer timelines to rebuild profitability absent structural pricing or cost improvements.
Weakened Free Cash Flow ConversionFCF down ~51% and covering only ~67.7% of net income signals poorer cash conversion from operations. Reduced FCF limits deleveraging, investment capacity and shareholder return optionality, increasing sensitivity to working capital swings and higher interest expense in the near term.
China Regulatory/export ConstraintsDRG pressures and export restrictions in China are structural and material for diagnostics and instruments. Localization and regulatory compliance require investment and can permanently reduce addressable markets, hampering medium‑term growth and complicating global supply and go‑to‑market strategies.
WAT FAQ
What was Waters Corp’s price range in the past 12 months?
Waters Corp lowest stock price was $275.05 and its highest was $414.15 in the past 12 months.
What is Waters Corp’s market cap?
Waters Corp’s market cap is $36.23B.
When is Waters Corp’s upcoming earnings report date?
Waters Corp’s upcoming earnings report date is Aug 04, 2026 which is in 14 days.
How were Waters Corp’s earnings last quarter?
Waters Corp released its earnings results on May 05, 2026. The company reported $2.7 earnings per share for the quarter, beating the consensus estimate of $2.307 by $0.393.
Is Waters Corp overvalued?
According to Wall Street analysts Waters Corp’s price is currently Undervalued.
Does Waters Corp pay dividends?
Waters Corp does not currently pay dividends.
What is Waters Corp’s EPS estimate?
Waters Corp’s EPS estimate is 3.01.
How many shares outstanding does Waters Corp have?
Waters Corp has 98,185,850 shares outstanding.
What happened to Waters Corp’s price movement after its last earnings report?
Waters Corp reported an EPS of $2.7 in its last earnings report, beating expectations of $2.307. Following the earnings report the stock price went up 13.538%.
Which hedge fund is a major shareholder of Waters Corp?
Currently, no hedge funds are holding shares in WAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Waters Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$403.33 (23.05% Upside)
$403.33 (23.05% Upside)
Blogger Sentiment
Bullish
WAT Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
434.26%
Trailing 12-Months
Company Description
Waters Corp
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
WAT Revenue Breakdown
34.81% Waters instrument systems
19.95% Chemistry consumables
34.13% Waters service
7.70% TA instrument systems
3.41% TA service

WAT Stock 12 Month Forecast
Average Price Target
$403.33
▲(23.05% Upside)
Technical Analysis
Ownership Overview
0.10% Insiders
29.76% Mutual Funds
0.55% Other Institutional Investors
43.06% Public Companies and
Individual Investors










